Is Medical Properties Trust (MPT) overvalued or fairly valued?

MarketChacha shows Medical Properties Trust's valuation in context — a forward P/E of about 40.1, a price-to-book of about 0.5 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Medical Properties Trust's revenue?

Medical Properties Trust reported revenue of $972.0M for FY2025, with net profit of $-277.0M, per official filings.

What is the share price of Medical Properties Trust (MPT)?

Medical Properties Trust last traded at $4.01 (-0.7% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Medical Properties Trust

MPT · NYSE · Real Estate · United States

Snapshot

TickerMPT

ExchangeNYSE

SectorReal Estate

IndustryREIT - Healthcare Facilities

CountryUnited States

Employees121

HeadquartersBirmingham, United States

Websitewww.medicalpropertiestrust.com

Filings tracked15

About Medical Properties Trust

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception, the Company has grown to become one of the world's largest owners of hospital real estate with 378 facilities and approximately 38,000 licensed beds in nine countries and across three continents as of March 31, 2026. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. Medical Properties Trust, Inc. is based in Alabama, Birmingham. Medical Properties Trust, Inc. was incorporated in 2003 in Maryland.

Who owns it

Insiders17.5%
Institutions63.0%
Public & other19.4%

634 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.12.60%
Vanguard Portfolio Management LLC7.33%
State Street Corporation4.21%
Vanguard Capital Management LLC3.64%
AQR Capital Management, LLC2.95%
Charles Schwab Investment Management, Inc.1.93%
Geode Capital Management, LLC1.67%
Wilsey Asset Management Inc1.27%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

Latest ROE of -6.0% is on the low side — the business earns a modest return on shareholder capital.

Net margin trend-63.8% → -28.5%

Margin has expanded by about 35.3 points — the business is getting more profitable.

Return on equity-6.0%

Latest ROE of -6.0% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $269.5M · EPS 0.01

Est. earnings growth -92.4%

Next fiscal year

Rev $1.1B · EPS 0.10

Est. earnings growth -9.1%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$972.0M

Net margin

-28.5%

ROE

-6.0%

Revenue CAGR (2y)

+5.6%

EPS (FY2025)

-0.46

Net profit (FY2025)

$-277.0M

Ask MarketChacha about MPT

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$972.0M	$-277.0M	-0.46	-28.5%	-6.0%
FY2024	$995.5M	$-2.4B	-4.02	-242.1%	-49.9%
FY2023	$871.8M	$-556.5M	-0.93	-63.8%	-7.3%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$252.1M	$32.8M	0.05	13.0%
2025Q3	$237.5M	$-77.7M	-0.13	-32.7%
2025Q2	$240.4M	$-98.4M	-0.16	-40.9%
2025Q1	$223.8M	$-118.3M	-0.20	-52.8%
2024Q3	$225.8M	$-801.2M	-1.34	-354.8%
2024Q2	$266.6M	$-320.6M	-0.54	-120.3%
2024Q1	$271.3M	$-875.6M	-1.46	-322.7%
2023Q3	$306.6M	$116.7M	0.19	38.1%
2023Q2	$337.4M	$-42.0M	-0.07	-12.5%
2023Q1	$350.2M	$32.8M	0.05	9.4%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Results of operations, Reg FD disclosure, Exhibits
SEC8/10/2026material
10-Q filing
SEC8/10/2026
8-K — Material agreement, Material financial obligation, Exhibits
SEC8/10/2026material
8-K — Shareholder vote results, Exhibits
SEC6/1/2026material
10-Q filing
SEC5/8/2026
8-K — Results of operations, Exhibits
SEC4/30/2026material
10-K filing
SEC2/26/2026
8-K — Results of operations, Exhibits
SEC2/19/2026material
8-K — Reg FD disclosure, Other events, Exhibits
SEC1/20/2026material

2025

10-Q filing
SEC11/7/2025
8-K — Results of operations, Other events, Exhibits
SEC10/30/2025material
8-K — Other events, Exhibits
SEC8/14/2025material
8-K — Other events, Exhibits
SEC8/11/2025material
10-Q filing
SEC8/8/2025
8-K — Results of operations, Exhibits
SEC7/31/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.